郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

代谢疾病Novel GPR120 Agonists with Improved Pharmacokinetic Profiles for the Treatment of Type 2 Diabetes.

期刊：Molecules (Basel, Switzerland)发表年份：2021作者：Guoxia Ji; Qinghua Guo; Qidi Xue; Ruifang Kong; Shiben Wang; Kang Lei; Renmin Liu; Xuekun Wang
阅读更多 →

代谢疾病Cell surface glycosaminoglycans exacerbate plasma membrane perturbation induced by the islet amyloid polypeptide.

期刊：FASEB journal : official publication of the Federation of American Societies for Experimental Biology发表年份：2021作者：Noé Quittot; Mathilde Fortier; Margaryta Babych; Phuong Trang Nguyen; Mathew Sebastiao; Steve Bourgault
阅读更多 →

代谢疾病Identification of efficient prokaryotic cell-penetrating peptides with applications in bacterial biotechnology.

期刊：Communications biology发表年份：2021作者：Hyang-Mi Lee; Jun Ren; Kha Mong Tran; Byeong-Min Jeon; Won-Ung Park; Hyunjoo Kim; Kyung Eun Lee; Yuna Oh; Myungback Choi; Dae-Sung Kim; Dokyun Na
阅读更多 →

代谢疾病AM833 Is a Novel Agonist of Calcitonin Family G Protein-Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective Agonists.

期刊：The Journal of pharmacology and experimental therapeutics发表年份：2021作者：Madeleine M Fletcher; Peter Keov; Tin T Truong; Grace Mennen; Caroline A Hick; Peishen Zhao; Sebastian G B Furness; Thomas Kruse; Trine R Clausen; Denise Wootten; Patrick M Sexton
阅读更多 →